Clinical Trials Logo

Clinical Trial Summary

Radical prostatectomy is a common treatment for localized prostate cancer. More than 30% of men who undergo surgery will subsequently develop recurrence, particularly in patients with adverse features where the risk may be even higher. Recurrence typically manifests as a rise in serum-level of prostate-specific antigen (PSA), referred to as biochemical recurrence. Post-operative radiotherapy is a potentially curative option for many patients, as shown in multiple prior randomized studies. A standard course of post-operative radiation requires 6 to 6 and half weeks of treatment, 5 days a week; however, new high-precision radiation techniques with image guidance, termed stereotactic body radiotherapy (SBRT), can deliver an equivalent or higher dose of treatment in 5 visits. Our group, amongst others, have demonstrated in previous studies, that the new 5-treatment technique was safe, convenient and effective in patients with intact prostates. Currently, limited data exists on this approach after prostatectomy. This study will be one of the first to assess the side effect profile and efficacy of SBRT in patients with localized prostate cancer who are considered candidates for post-prostatectomy radiation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04067570
Study type Interventional
Source Sunnybrook Health Sciences Centre
Contact Principle Investigator
Phone 416 480 4998
Email chia-lin.tseng@sunnybrook.ca
Status Recruiting
Phase N/A
Start date November 7, 2019
Completion date October 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04059341 - Early Extracorporeal Shockwave Therapy for Erectile Dysfunction in Radically Prostatectomised Men. N/A
Recruiting NCT04687969 - Multimodal Machine Learning Characterization of Solid Tumors
Recruiting NCT05625048 - Urinary Incontinence After Radical Prostatectomy N/A
Recruiting NCT05558007 - Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients Phase 2
Completed NCT05332340 - Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered Phase 1
Enrolling by invitation NCT04399876 - Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer Phase 1
Active, not recruiting NCT01540656 - Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence Phase 3
Terminated NCT01220427 - Micro-RNA Expression Profiles in High Risk Prostate Cancer N/A
Not yet recruiting NCT06351579 - Data Collection Post Radical Prostatectomy
Completed NCT03639389 - Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy Phase 3
Completed NCT04862533 - Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA) N/A
Completed NCT03587402 - Effects of Transcutaneous Perineal Stimulation Versus Anal Stimulation N/A
Withdrawn NCT03338712 - Micro-RNA Expression Profiles in Localised Prostate Cancer
Recruiting NCT06085664 - A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy Phase 1/Phase 2
Terminated NCT00955929 - Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy N/A
Completed NCT00953277 - Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer Phase 4
Recruiting NCT06275945 - Feasibility Study of A VoRo UrologIc ScaffolD (ARID) Phase 2
Completed NCT04587505 - Effect of Epidural Anesthesia and Analgesia on Quality of Recovery After Radical Prostatectomy. Phase 4